We’ve all heard of HIV—the ominous, life-threatening disease that spread via the transfer of bodily fluids between humans. First emerging in 1981, HIV is one of the most persistent and deadliest pandemics humanity has ever seen and till this day, no one has found a cure for it yet.
HIV attacks the cells in the body that fights infections, so if left untreated over a long period of time, the immune system becomes completely vulnerable. This will invite the deadly infection called AIDS, and at this stage, a patient’s life expectancy drastically plummets to three years.
There exist, however, treatments for this virus, in the form or Anti-Retroviral Therapy (ART) drugs. If administered to patients in the early stages of HIV infection, it can prevent AIDS altogether, allowing them to lead full and productive lives.
These drugs also render HIV patients non-infectious to their sexual partners, therefore stemming the spread of this fatal disease. However, ART drugs cost money, and if you have HIV, it means that you will likely need to continuously pay for these for the rest of your life.
For the first time ever in Singapore, patients suffering from HIV can now receive subsidies for their medication. On September 1st 2020, ART drugs like Abacavir, Lamivudine and Dolutegravir were officially listed on the Standard Drug List by the Ministry Of Health. Today, Singaporeans and Permanent Residents can obtain them for a subsidised fee.
This is a huge step forward for all those suffering from HIV, as well as organisations like Action For AIDS (AfA) in curbing the spread of the disease in Singapore. For more information on where and how you can be eligible for this subsidy, click here.
We're hiring lifestyle writers!